These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31146625)
1. Gastrointestinal Stromal Tumors Risk Stratification Utilizing Phospho-Histone H3 Evaluated by Manual Counting and Computer-Assisted Image Analysis. Jin C; Huang Y; Nasim M; Yang Y; Lee L Int J Surg Pathol; 2019 Oct; 27(7):706-712. PubMed ID: 31146625 [No Abstract] [Full Text] [Related]
2. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors. Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616 [TBL] [Abstract][Full Text] [Related]
3. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors. Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585 [TBL] [Abstract][Full Text] [Related]
5. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026 [TBL] [Abstract][Full Text] [Related]
6. Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiency. Laflamme P; Mansoori BK; Sazanova O; Orain M; Couture C; Simard S; Trahan S; Manem V; Joubert P Hum Pathol; 2020 Dec; 106():74-81. PubMed ID: 33007357 [TBL] [Abstract][Full Text] [Related]
7. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215 [TBL] [Abstract][Full Text] [Related]
9. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies. Puripat N; Loharamtaweethong K Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302 [TBL] [Abstract][Full Text] [Related]
10. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast. Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415 [TBL] [Abstract][Full Text] [Related]
11. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody. Medani H; Elshiekh M; Naresh KN J Clin Pathol; 2021 Oct; 74(10):646-649. PubMed ID: 32873701 [TBL] [Abstract][Full Text] [Related]
12. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma. Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900 [TBL] [Abstract][Full Text] [Related]
13. Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray. Dessauvagie BF; Thomas C; Robinson C; Frost FA; Harvey J; Sterrett GF Pathology; 2015 Jun; 47(4):329-34. PubMed ID: 25938351 [TBL] [Abstract][Full Text] [Related]
14. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Veras E; Malpica A; Deavers MT; Silva EG Int J Gynecol Pathol; 2009 Jul; 28(4):316-21. PubMed ID: 19483635 [TBL] [Abstract][Full Text] [Related]
15. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors. Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796 [TBL] [Abstract][Full Text] [Related]
16. Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma. Nielsen PS; Riber-Hansen R; Schmidt H; Steiniche T Diagn Pathol; 2016 Apr; 11():35. PubMed ID: 27062658 [TBL] [Abstract][Full Text] [Related]
17. PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors. Shin Y; Hyeon J; Lee B; Ha SY; Hong ME; Do IG; Kim KM J Pathol Transl Med; 2015 Jan; 49(1):23-9. PubMed ID: 25812654 [TBL] [Abstract][Full Text] [Related]
18. Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count? Erhan SS; Sensu S; Keser SH; Kangal E; Gul AE; Gundogan GA; Sakin A Sisli Etfal Hastan Tip Bul; 2022; 56(2):276-283. PubMed ID: 35990307 [TBL] [Abstract][Full Text] [Related]
19. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors. Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133 [TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia. Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]